Diabetes, Obesity and Metabolism, 1462-8902

Journal

More filtering options
  1. 2007
  2. Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial

    S. S. Lund, L. Tarnow, C. D. A. Stehouwer, C. G. Schalkwijk, M. Frandsen, U. M. Smidt, O. Pedersen, H. -H. Parving & Allan Vaag, 2007, In : Diabetes, Obesity and Metabolism. 9, 3, p. 394-407

    Research output: Contribution to journalArticle

  3. 2006
  4. 2005
  5. Islet adaptation to insulin resistance: mechanisms and implications for intervention.

    Bo Ahrén & G Pacini, 2005, In : Diabetes, Obesity and Metabolism. 7, 1, p. 2-8

    Research output: Contribution to journalReview article

  6. 2004
  7. Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community.

    Carl Johan Östgren, Juan Merlo, Lennart Råstam & Ulf Lindblad, 2004, In : Diabetes, Obesity and Metabolism. 6, 5, p. 367-374

    Research output: Contribution to journalArticle

  8. 2003
  9. Metabolic disorders associated with uncontrolled hypertension.

    Erik Bøg-Hansen, Ulf Lindblad, Bo Gullberg, Arne Melander & Lennart Råstam, 2003, In : Diabetes, Obesity and Metabolism. 5, 6, p. 379-387

    Research output: Contribution to journalArticle

  10. Socio-demographic and psychosocial factors are associated with features of the metabolic syndrome. The Women's Health in the Lund Area (WHILA) study.

    Jonas Lidfeldt, P Nyberg, Christina Nerbrand, Göran Samsioe, Bengt Scherstén & Carl-David Agardh, 2003, In : Diabetes, Obesity and Metabolism. 5, 2, p. 106-112

    Research output: Contribution to journalArticle

  11. 2002
  12. Efficacy, effectiveness and safety of sulphonylurea-metformin combination therapy in patients with type 2 diabetes.

    LS. Hermann, Gunnar Lindberg, Ulf Lindblad & Arne Melander, 2002, In : Diabetes, Obesity and Metabolism. 4, 5, p. 296-304

    Research output: Contribution to journalReview article

  13. 2001
  14. Effects and serum levels of glibenclamide and its active metabolites in patients with type 2 diabetes

    A. Jönsson, Bengt Hallengren, T. Rydberg & A. Melander, 2001, In : Diabetes, Obesity and Metabolism. 3, 6, p. 403-409

    Research output: Contribution to journalArticle

  15. Impaired glucose metabolism and obesity in Swedish patients with borderline isolated systolic hypertension: Skaraborg Hypertension and Diabetes Project

    Erik Bøg-Hansen, Ulf Lindblad, J Ranstam, Arne Melander & Lennart Råstam, 2001, In : Diabetes, Obesity and Metabolism. 3, 1, p. 25-31

    Research output: Contribution to journalArticle

  16. 1999
  17. Differences in treatment and metabolic abnormalities between normo- and hypertensive patients with type 2 diabetes: the Skaraborg Hypertension and Diabetes Project

    Carl Johan Östgren, Ulf Lindblad, Erik Bøg-Hansen, Jonas Ranstam, Arne Melander & Lennart Råstam, 1999, In : Diabetes, Obesity and Metabolism. 1, 2, p. 105-112

    Research output: Contribution to journalArticle

Previous 1 2 Next